Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis)
- 1 December 1989
- journal article
- Published by Elsevier in Kidney International
- Vol. 36 (6), 1061-1068
- https://doi.org/10.1038/ki.1989.301
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Deferoxamine Treatment as a Risk Factor for Zygomycete InfectionThe Journal of Infectious Diseases, 1989
- Treatment of Experimental Zygomycosis in Guinea Pigs with Azoles and with Amphotericin BChemotherapy, 1989
- Cunninghamella bertholletiae Infection Associated with Deferoxamine TherapyClinical Infectious Diseases, 1988
- Experimental Zygomycosis Due to Rhizopus spp. Infection by Various Routes in Guinea‐Pigs, Rats and MiceMycoses, 1988
- Adjunctive Hyperbaric Oxygen for Treatment of Rhinocerebral MucormycosisClinical Infectious Diseases, 1988
- Rhinocerebral Mucormycosis in an Anephric PatientSouthern Medical Journal, 1988
- High-performance liquid chromatography of siderophores from fungiBioMetals, 1988
- Use of Deferoxamine in the Treatment of Aluminum Overload in Dialysis PatientsSeminars in Dialysis, 1988
- Fatal Phycomycosis in a Hemodialyzed Patient Receiving DeferoxamineNephron, 1988
- FACTORS DETERMINING THE SUSCEPTIBILITY OF MICE TO EXPERIMENTAL PHYCOMYCOSISJournal of Medical Microbiology, 1975